Eli Lilly and Company (LLY.DE)

EUR 740.8

(-1.23%)

Long Term Debt Summary of Eli Lilly and Company

  • Eli Lilly and Company's latest annual long term debt in 2023 was 18.32 Billion USD , up 24.31% from previous year.
  • Eli Lilly and Company's latest quarterly long term debt in 2024 Q3 was 29.04 Billion USD , up 21.79% from previous quarter.
  • Eli Lilly and Company reported annual long term debt of 14.73 Billion USD in 2022, down -3.97% from previous year.
  • Eli Lilly and Company reported annual long term debt of 15.34 Billion USD in 2021, down -7.48% from previous year.
  • Eli Lilly and Company reported quarterly long term debt of 29.04 Billion USD for 2024 Q3, up 21.79% from previous quarter.
  • Eli Lilly and Company reported quarterly long term debt of 24.55 Billion USD for 2024 Q1, up 33.3% from previous quarter.

Annual Long Term Debt Chart of Eli Lilly and Company (2023 - 1989)

Historical Annual Long Term Debt of Eli Lilly and Company (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 18.32 Billion USD 24.31%
2022 14.73 Billion USD -3.97%
2021 15.34 Billion USD -7.48%
2020 16.58 Billion USD 15.95%
2019 14.3 Billion USD 55.55%
2018 9.19 Billion USD -7.49%
2017 9.94 Billion USD 18.79%
2016 8.36 Billion USD 4.96%
2015 7.97 Billion USD 48.53%
2014 5.36 Billion USD 27.79%
2013 4.2 Billion USD -23.9%
2012 5.51 Billion USD 1.0%
2011 5.46 Billion USD -19.29%
2010 6.77 Billion USD 2.05%
2009 6.63 Billion USD 43.74%
2008 4.61 Billion USD 0.48%
2007 4.59 Billion USD 31.45%
2006 3.49 Billion USD -39.37%
2005 5.76 Billion USD 28.31%
2004 4.49 Billion USD -4.18%
2003 4.68 Billion USD 7.56%
2002 4.35 Billion USD 39.15%
2001 3.13 Billion USD 18.92%
2000 2.63 Billion USD -6.34%
1999 2.81 Billion USD 28.66%
1998 2.18 Billion USD -6.04%
1997 2.32 Billion USD -7.57%
1996 2.51 Billion USD -2.95%
1995 2.59 Billion USD 21.97%
1994 2.12 Billion USD 154.53%
1993 835.2 Million USD 43.43%
1992 582.3 Million USD 47.23%
1991 395.5 Million USD 42.78%
1990 277 Million USD 2.78%
1989 269.5 Million USD -30.49%

Peer Long Term Debt Comparison of Eli Lilly and Company

Name Long Term Debt Long Term Debt Difference
Bayer Aktiengesellschaft 37.23 Billion EUR 50.793%
Sanofi 14.34 Billion EUR -27.698%